Cargando…
Disease phenotype prediction in multiple sclerosis
Progressive multiple sclerosis (PMS) is currently diagnosed retrospectively. Here, we work toward a set of biomarkers that could assist in early diagnosis of PMS. A selection of cerebrospinal fluid metabolites (n = 15) was shown to differentiate between PMS and its preceding phenotype in an independ...
Autores principales: | Herman, Stephanie, Arvidsson McShane, Staffan, Zjukovskaja, Christina, Khoonsari, Payam Emami, Svenningsson, Anders, Burman, Joachim, Spjuth, Ola, Kultima, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275960/ https://www.ncbi.nlm.nih.gov/pubmed/37332601 http://dx.doi.org/10.1016/j.isci.2023.106906 |
Ejemplares similares
-
Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
por: Carlsson, Henrik, et al.
Publicado: (2020) -
Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2018) -
Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023) -
Container-based bioinformatics with Pachyderm
por: Novella, Jon Ander, et al.
Publicado: (2019) -
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
por: Herman, Stephanie, et al.
Publicado: (2019)